Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Mice Model Technologies Market to Reach Value of US$ 3.2 Bn by 2031: TMR Study


WILMINGTON, Del., Aug. 17, 2022 /PRNewswire/ -- Steady rise in R&D on drug discovery and chronic diseases has continually expanded the mice model technologies market size. Biotechnology companies have emerged as a primary user of genetically engineered mouse models, and the segment is projected to account for a major mice model technologies market share during the forecast period. The global mice model technologies market is estimated to advance at a CAGR of 7.4% from 2022 to 2031.

TMR_Logo_Logo

Recent mice model technologies market size trends indicate that with the introduction of emerging gene editing techniques particularly CRISPR/Cas9, companies have witnessed tremendous opportunities. Unmet need for efficacious therapeutics for infectious disease, diabetes, and oncology has spurred the commercialization of NOD SCID gamma mouse, found the TMR analysts. Emergence of mouse xenograft models for use in human cancer therapeutics research is a notable case in point, which will boost the future market outlook for mice model technologies.

With the healthcare industry intent on applying patient-specific therapies, the personalized medicine is expanding in scope. This presents a new avenue for developing new mouse models, thereby enriching the value chain of players in the mice model technologies market.

Get Exclusive PDF Sample Copy of Mice Model Technologies Market Report ? https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84893 

Key Findings of Mice Model Technologies Market Study

Ask for References ? https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84893 

Mice Model Technologies Market: Key Drivers

Mice Model Technologies Market: Regional Growth Dynamics

Make an Enquiry Before Buying ? https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84893 

Mice Model Technologies Market: Competition Landscape

Key players in the mice model technologies market are engaging in collaborations, forging partnership, and entering into joint ventures in order to gain shares by the end of the forecast period.

The presence of several global and regional players renders the competition landscape fairly fragmented. Key players include The Jackson Laboratory, Columbia University, University of Bonn, Monash University, University of North Carolina, Yale School of Medicine, PolyGene AG, Ozgene Pty Ltd., Merck KGaA, Gempharmatech, Cyagen Biosciences, Charles River Laboratories, and BIOCYTOGEN.

Mice Model Technologies Market Segmentation

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Animal Genetics Market: The global animal genetics market is anticipated to reach more than US$ 9.1 Bn by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Soft Tissue Allografts Market: The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031 with a CAGR of 5.5% from 2022 to 2031.

PRP and PRF in Cosmetics Market: The global PRP and PRF in cosmetics market is anticipated to exceed US$ 483 Mn by 2031 with a CAGR of 12.6% from 2022 to 2031.

Fetal Bovine Serum Market: The global fetal bovine serum market is expected to surpass the value of US$ 1.6 Bn by the end of 2031 with a CAGR of 6.4% from 2021 to 2031.

Cell Culture Market: The global cell culture market is expected to reach the value of US$ 27.6 Bn by the end of 2031 with a CAGR of 9% from 2021 to 2031.

Bioprocess Technology Market: The global bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031 with a CAGR of 8.3% from 2021 to 2031.

Medical Waste Management Market: The global medical waste management market is expected to reach the value of US$ 25.2 Bn by the end of 2028 with a CAGR of 6.2% from 2021 to 2028.

Molecular Diagnostics Market: The global molecular diagnostics market is expected to reach the value of US$ 37.19 Bn by the end of 2028 with a CAGR of 11.1% from 2021 to 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA ? Canada Toll Free: 866-552-3453
Websitehttps://www.transparencymarketresearch.com
Bloghttps://tmrblog.com
Email: [email protected]

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: